Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jacob Litorell"'
Autor:
Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, Jonathan Grip, Mårten Söderberg, Jacob Hollenberg, Rebecka Rubenson Wahlin, Thomas Kander, Liivi Rimling, Johan Mårtensson, Eva Joelsson-Alm, Martin Dahlberg, Maria Cronhjort
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with critical COVID-19 have a high risk of thromboembolism, but intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-weight heparins can be monitored by measuring anti-Factor Xa. We
Externí odkaz:
https://doaj.org/article/198c0dae5b6846be8b392a23e45025fa
Autor:
Sandra Jonmarker, Felix Alarcón, Jacob Litorell, Anders Granholm, Eva Joelsson Alm, Michelle Chew, Lene Russell, Sarah Weihe, Emilie Kabel Madsen, Nick Meier, Jens Wolfgang Leistner, Johan Mårtensson, Jacob Hollenberg, Anders Perner, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Martin Dahlberg, Maria Cronhjort, Rebecka Rubenson Wahlin
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Thromboembolism is more common in patients with critical COVID-19 than in other critically ill patients, and inflammation has been proposed as a possible mechanism. The aim of this study was to investigate if 12 mg vs. 6 mg dexame
Externí odkaz:
https://doaj.org/article/3731ee9446b7446d83c1c7da2859941b
Autor:
Sandra Jonmarker, Jacob Litorell, Martin Dahlberg, Otto Stackelberg, Åsa H. Everhov, Mårten Söderberg, Rebecka Rubenson‐Wahlin, Mattias Günther, Johan Mårtensson, Jacob Hollenberg, Eva Joelsson‐Alm, Maria Cronhjort
Publikováno v:
Acta Anaesthesiologica Scandinavica. 66:365-374
Critically ill COVID-19 patients have a high reported incidence of thromboembolic complications and the optimal dose of thromboprophylaxis is not yet determined. The aim of this study was to investigate if 90-day mortality differed between patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb87f608d357087d88b7c3db5cd972d
https://doi.org/10.1111/aas.14013
https://doi.org/10.1111/aas.14013
Autor:
Hans Järnbert-Pettersson, Mårten Söderberg, Martin Dahlberg, Anna Schandl, Jacob Litorell, Jacob Hollenberg, Jonathan Grip, Maria Cronhjort, Åsa H Everhov, Otto Stackelberg, Sandra Jonmarker, Mattias Günther
Publikováno v:
Critical Care
Background A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00827808f11de3d46f8c7f3543911b1d
https://doi.org/10.1186/s13054-020-03375-7
https://doi.org/10.1186/s13054-020-03375-7